[go: up one dir, main page]

DK4026917T5 - Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse - Google Patents

Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse Download PDF

Info

Publication number
DK4026917T5
DK4026917T5 DK22158931.0T DK22158931T DK4026917T5 DK 4026917 T5 DK4026917 T5 DK 4026917T5 DK 22158931 T DK22158931 T DK 22158931T DK 4026917 T5 DK4026917 T5 DK 4026917T5
Authority
DK
Denmark
Prior art keywords
tissue
dna
cell
kit
methylation analysis
Prior art date
Application number
DK22158931.0T
Other languages
English (en)
Other versions
DK4026917T3 (da
Inventor
Yuval Dor
Ruth Shemer
Benjamin Glaser
Original Assignee
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd, Hadasit Med Res Service filed Critical Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd
Application granted granted Critical
Publication of DK4026917T3 publication Critical patent/DK4026917T3/da
Publication of DK4026917T5 publication Critical patent/DK4026917T5/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK22158931.0T 2014-04-14 2015-04-14 Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse DK4026917T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461979233P 2014-04-14 2014-04-14
EP19209237.7A EP3643795B1 (en) 2014-04-14 2015-04-14 A method for determining the death of cells or tissue by dna methylation analysis

Publications (2)

Publication Number Publication Date
DK4026917T3 DK4026917T3 (da) 2024-02-12
DK4026917T5 true DK4026917T5 (da) 2024-07-15

Family

ID=53051869

Family Applications (2)

Application Number Title Priority Date Filing Date
DK22158931.0T DK4026917T5 (da) 2014-04-14 2015-04-14 Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse
DK19209237.7T DK3643795T3 (da) 2014-04-14 2015-04-14 Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19209237.7T DK3643795T3 (da) 2014-04-14 2015-04-14 Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering

Country Status (14)

Country Link
US (3) US11203784B2 (da)
EP (4) EP3643795B1 (da)
JP (1) JP6750879B2 (da)
CN (1) CN106574296B (da)
DK (2) DK4026917T5 (da)
ES (1) ES2974838T3 (da)
FI (1) FI4026917T3 (da)
HR (1) HRP20240189T1 (da)
IL (1) IL248299B (da)
LT (1) LT4026917T (da)
PL (1) PL4026917T3 (da)
PT (1) PT4026917T (da)
SI (1) SI4026917T1 (da)
WO (2) WO2015159293A2 (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
EP4424826A3 (en) 2012-09-04 2024-11-27 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
SG11201604923XA (en) 2013-12-28 2016-07-28 Guardant Health Inc Methods and systems for detecting genetic variants
PL4026917T3 (pl) 2014-04-14 2024-04-08 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Metoda i zestaw do określania śmierci komórek lub tkanek albo tkankowego lub komórkowego pochodzenia dna za pomocą analizy metylacji dna
WO2016008451A1 (en) 2014-07-18 2016-01-21 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in dna mixture
EP4063517A1 (en) 2015-07-20 2022-09-28 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
JP2019507585A (ja) 2015-12-17 2019-03-22 ガーダント ヘルス, インコーポレイテッド 無細胞dnaの分析による腫瘍遺伝子コピー数を決定するための方法
US11384382B2 (en) 2016-04-14 2022-07-12 Guardant Health, Inc. Methods of attaching adapters to sample nucleic acids
ES3002715T3 (en) 2016-04-14 2025-03-07 Guardant Health Inc Methods for early detection of cancer
WO2017201606A1 (en) 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
AU2017274038B2 (en) * 2016-05-30 2023-03-16 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free DNA in blood
EP3464644A4 (en) * 2016-06-07 2020-07-15 The Regents of The University of California PATTERNS OF ACELLULAR DNA METHYLATION FOR ANALYSIS OF DISEASES AND CONDITIONS
EP3500687A4 (en) 2016-08-17 2020-07-29 The Regents of the University of California NEW METHOD BASED ON AN IMMUNOSOND, ALLOWING THE EVALUATION OF AN ORGANIC DAMAGE STATUS BY AN ACELLULAR DNA ASSAY (CFDNA) BASED ON BIOFLUID
US11959125B2 (en) * 2016-09-15 2024-04-16 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
EP3535415A4 (en) 2016-10-24 2020-07-01 The Chinese University of Hong Kong TUMOR DETECTION METHODS AND SYSTEMS
AU2017369018B2 (en) 2016-11-30 2021-02-25 The Chinese University Of Hong Kong Analysis of cell-free DNA in urine and other samples
CA3046007A1 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
WO2018187521A2 (en) 2017-04-06 2018-10-11 Cornell University Methods of detecting cell-free dna in biological samples
CN111032868A (zh) * 2017-06-30 2020-04-17 加利福尼亚大学董事会 用于评估无细胞dna中的dna甲基化的方法和系统
WO2019012544A1 (en) 2017-07-13 2019-01-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. STRATEGY FOR DOUBLE PROBE DROPLETS FOR SPECIFIC DETECTION OF CIRCULATING DNA MOLECULES SPECIFIC TO A TISSUE
WO2019012542A1 (en) 2017-07-13 2019-01-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. DETECTION OF SPECIFIC DNA FROM A FABRIC
EP3652344A1 (en) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Dna targets as tissue-specific methylation markers
CN111051536A (zh) 2017-07-26 2020-04-21 香港中文大学 利用不含细胞的病毒核酸改善癌症筛选
DE102017126248B4 (de) 2017-11-09 2019-10-17 Epiontis Gmbh ERGIC1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesonderemonozytischem myeloid-abgeleiteten Suppressor-Zellen (mMDSCs)
EP3752641A1 (en) * 2018-02-18 2020-12-23 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Cell free dna deconvolution and use thereof
EP3765637A1 (en) 2018-03-13 2021-01-20 Grail, Inc. Anomalous fragment detection and classification
EP3765638A2 (en) * 2018-03-13 2021-01-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Diagnostic use of cell free dna chromatin immunoprecipitation
JP7620803B2 (ja) * 2018-03-15 2025-01-24 グレイル インコーポレイテッド 組織特異的メチル化マーカー
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
JP2021112127A (ja) * 2018-04-26 2021-08-05 暁生 黒田 膵β細胞の傷害検査方法
AU2019277698A1 (en) 2018-06-01 2020-11-19 Grail, Llc Convolutional neural network systems and methods for data classification
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
KR20210141915A (ko) 2018-11-21 2021-11-23 아비다 바이오메드 인코포레이티드 표적화된 핵산 라이브러리 형성을 위한 방법
US11581062B2 (en) 2018-12-10 2023-02-14 Grail, Llc Systems and methods for classifying patients with respect to multiple cancer classes
AU2019401636A1 (en) * 2018-12-18 2021-06-17 Grail, Llc Systems and methods for estimating cell source fractions using methylation information
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
WO2020155149A1 (en) * 2019-02-02 2020-08-06 Lenovo (Beijing) Limited Enhanced scheduling of time sensitive networking
IL265451B (en) 2019-03-18 2020-01-30 Frumkin Dan Methods and systems for the detection of methylation changes in DNA samples
WO2020202162A1 (en) * 2019-04-03 2020-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Primers for multiplex pcr
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
US12497662B2 (en) 2019-04-16 2025-12-16 Grail, Inc. Systems and methods for tumor fraction estimation from small variants
US11001898B2 (en) 2019-05-31 2021-05-11 Universal Diagnostics, S.L. Detection of colorectal cancer
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
WO2021067484A1 (en) 2019-09-30 2021-04-08 Guardant Health, Inc. Compositions and methods for analyzing cell-free dna in methylation partitioning assays
KR102103885B1 (ko) * 2019-10-08 2020-04-24 주식회사 레피다인 생물학적 시료의 간 조직 유래 여부를 판별하는 방법
AU2020365150A1 (en) * 2019-10-18 2022-05-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for measuring cell states
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
GB2603051B (en) 2020-01-30 2023-04-26 Prognomiq Inc Lung biomarkers and methods of use thereof
GB2612412B (en) 2020-01-31 2025-10-10 Agilent Technologies Inc Systems and methods for targeted nucleic acid capture
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
US20230220459A1 (en) * 2020-06-10 2023-07-13 Ramot At Tel-Aviv University Ltd. METHODS OF DETECTING METHYLATED CpG
WO2022002424A1 (en) 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
EP4232599A1 (en) 2020-10-23 2023-08-30 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and base conversion
WO2022133159A1 (en) 2020-12-17 2022-06-23 Nephrosant, Inc. Kits for stabilization of urine samples
WO2022212583A1 (en) 2021-03-31 2022-10-06 PrognomIQ, Inc. Multi-omic assessment
WO2023039479A1 (en) 2021-09-10 2023-03-16 PrognomIQ, Inc. Direct classification of raw biomolecule measurement data
JP2024534992A (ja) 2021-09-13 2024-09-26 プログノミック インコーポレイテッド 生体分子の増強された検出および定量
AU2022424000A1 (en) * 2021-12-30 2024-07-11 GRAIL, Inc Compositions and methods for identifying cell types
WO2023178109A2 (en) * 2022-03-15 2023-09-21 Resonant Llc Neuronal methylation signatures from cell free dna as a pre-symptomatic neurodegenerative condition surveillance diagnostic
EP4573217A1 (en) 2022-08-18 2025-06-25 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. A method for determining the tissue or cell of origin of dna
US20250043351A1 (en) * 2023-08-02 2025-02-06 Resonant Llc Neuronal methylation signatures from cell free dna and methods of use thereof
WO2025034580A1 (en) * 2023-08-04 2025-02-13 Pupil Bio, Inc. Phase methylation-based markers for tissue and cell-type-specific identification and monitoring
WO2025178881A1 (en) * 2024-02-20 2025-08-28 Singlera Genomics Inc. Methods and compositions for assessing tissue and organ damage

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
KR100236506B1 (ko) 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 폴리머라제 연쇄 반응 수행 장치
CA2074214C (en) 1991-07-23 2000-02-22 Will Bloch Improvements in the in situ pcr
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5612473A (en) 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
CA2305711A1 (en) * 1997-10-07 1999-04-15 Merck & Co., Inc. Assays for nuclear receptor ligands using fret
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
EP1451354A2 (en) * 2001-11-23 2004-09-01 Epigenomics AG Method and nucleic acids for the analysis of a lymphoid cell proliferative disorder
DE60207979T2 (de) 2002-03-05 2006-09-28 Epigenomics Ag Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
US7709194B2 (en) 2004-06-04 2010-05-04 The Chinese University Of Hong Kong Marker for prenatal diagnosis and monitoring
EP3101141B1 (en) 2007-06-08 2019-10-16 Epigenomics AG Method for methylation analysis
RU2503088C2 (ru) 2009-07-01 2013-12-27 Шарп Кабусики Кайся Подложка с активной матрицей и органическое электролюминесцентное устройство отображения
WO2011101728A2 (en) 2010-02-19 2011-08-25 Nucleix Identification of source of dna samples
WO2011132061A2 (en) 2010-04-20 2011-10-27 Nucleix Methylation profiling of dna samples
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
WO2012047091A1 (en) * 2010-10-08 2012-04-12 Universiti Putra Malaysia Glp-1 promoter mediated insulin expression for the treatment of diabetes
US20130084328A1 (en) * 2011-04-27 2013-04-04 Sanford-Burnham Medical Research Institute Methylated coding and non-coding rna genes as diagnostic and therapeutic tools for human melanoma
EP2723901B1 (en) * 2011-06-22 2018-08-08 Yale University Compositions and methods of diagnosing diseases and disorders associated with cell death
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
US9127317B2 (en) 2012-03-02 2015-09-08 Winthrop-University Hospital Method for using probe based PCR detection to measure the levels of circulating demethylated β cell derived DNA as a measure of β cell loss in diabetes
CN104486990B (zh) 2012-07-20 2017-07-04 株式会社村田制作所 生物传感器
WO2014138133A1 (en) 2013-03-04 2014-09-12 Islet Sciences, Inc. Compositions and methods for detecting hypo-methylated dna in body fluids
WO2014149356A1 (en) 2013-03-15 2014-09-25 Abbott Molecular Inc. Detection of bisulfite converted nucleotide sequences
PL4026917T3 (pl) 2014-04-14 2024-04-08 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Metoda i zestaw do określania śmierci komórek lub tkanek albo tkankowego lub komórkowego pochodzenia dna za pomocą analizy metylacji dna
WO2015169947A1 (en) 2014-05-09 2015-11-12 Lifecodexx Ag Detection of dna that originates from a specific cell-type and related methods
WO2017011390A1 (en) 2015-07-10 2017-01-19 Winthrop-University Hospital System, method and kit for analysis of circulating differentially methylated dna as a biomarker of b-cell loss
WO2019012542A1 (en) 2017-07-13 2019-01-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. DETECTION OF SPECIFIC DNA FROM A FABRIC
EP3652344A1 (en) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Dna targets as tissue-specific methylation markers
WO2019012544A1 (en) 2017-07-13 2019-01-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. STRATEGY FOR DOUBLE PROBE DROPLETS FOR SPECIFIC DETECTION OF CIRCULATING DNA MOLECULES SPECIFIC TO A TISSUE

Also Published As

Publication number Publication date
US20220064730A1 (en) 2022-03-03
EP3643795B1 (en) 2022-03-30
US11203784B2 (en) 2021-12-21
US20230242985A1 (en) 2023-08-03
US20170121767A1 (en) 2017-05-04
EP4306659A2 (en) 2024-01-17
WO2015159292A2 (en) 2015-10-22
CN106574296B (zh) 2021-03-02
WO2015159293A2 (en) 2015-10-22
EP4026917A1 (en) 2022-07-13
CN106574296A (zh) 2017-04-19
WO2015159293A3 (en) 2015-12-10
IL248299B (en) 2021-04-29
EP4306659A3 (en) 2024-03-27
SI4026917T1 (sl) 2024-05-31
EP4026917B1 (en) 2023-11-15
DK4026917T3 (da) 2024-02-12
HRP20240189T1 (hr) 2024-04-26
DK3643795T3 (da) 2022-05-09
WO2015159292A3 (en) 2015-12-10
EP3132055A2 (en) 2017-02-22
JP6750879B2 (ja) 2020-09-02
EP3643795A1 (en) 2020-04-29
FI4026917T3 (fi) 2024-02-14
PL4026917T3 (pl) 2024-04-08
JP2017511142A (ja) 2017-04-20
LT4026917T (lt) 2024-03-12
PT4026917T (pt) 2024-02-12
IL248299A0 (en) 2016-11-30
ES2974838T3 (es) 2024-07-01

Similar Documents

Publication Publication Date Title
DK4026917T3 (da) Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse
IL283416A (en) Genomic infrastructure for on-site or cloud-based dna and rna processing and analysis
DK3325669T3 (da) Sammensætninger og fremgangsmåder til RNA-analyse
DK3882357T3 (da) Fremgangsmåder og sammensætninger til analyse af nukleinsyrer
DK3114225T3 (da) Sammensætning og fremgangsmåde til stabilisering af nukleinsyrer i biologiske prøver
IL253860B (en) Devices for biological sample collection and analysis and methods of use thereof
IL281579B (en) Compositions and methods for detecting a biological contaminant
IL249618A0 (en) Methods and preparations for analyzing samples
DK3294325T3 (da) Forbedring af virkningen af car-manipulerede t-celler ved hjælp af nukleinsyrevaccination
DK3408407T3 (da) Fremgangsmåder til påvisning af cpg-methylering af tumorafledt dna i blodprøver
DK3149019T3 (da) Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme
SG10202103903UA (en) Systems and methods for assessing biological samples
EP3158085A4 (en) Methods, compositions, and devices for rapid analysis of biological markers
EP3097399A4 (en) Workflow for resaturation and analysis of unconventional core samples
EP3315596A4 (en) CELL CULTURE CONTAINER
DK3284816T3 (da) Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme
DK3145634T3 (da) Prøveudtagnings- og analysekit, prøveholder og fremgangsmåde
DK3739061T3 (da) Methyleringsmønsteranalyse af haplotyper i væv i DNA-blanding
DK3471733T3 (da) Reagenser, sammensætninger og fremgangsmåder til forbedring af cellers, vævs og organers levedygtighed og funktion
DK3155421T3 (da) Beholder til bestemmelse af analytter og/eller kemisk-fysiske parametre og til bestemmelse af urinsediment i urin og fremgangsmåde til fuld urinanalyse ved anvendelse af denne beholder
PL3403579T3 (pl) Zarządzanie próbkami krwi z wykorzystaniem pianki o otwartych komórkach
GB2562858B (en) Method for the cytometric analysis of cell samples
GB201413857D0 (en) Water sample analysis kit
EP3303605C0 (en) MULTI-MEDIATOR REAGENT FORMULATIONS FOR USE IN ELECTROCHEMICAL DETECTION
DK3271864T3 (da) Vævsprøveanalyseteknik